HUTCHMED (China) Ltd - SPONSORED ADS (HCM)

Historical Holders from Q1 2016 to Q3 2025

Symbol
HCM on Nasdaq
Type / Class
Equity / SPONSORED ADS
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,761,615
Holdings value
$90,656,720
% of all portfolios
0%
Number of holders
55
Number of buys
22
Number of sells
28
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
64 filings reported holding HCM - HUTCHMED (China) Ltd - SPONSORED ADS as of 30 Sep 2025.
HUTCHMED (China) Ltd - SPONSORED ADS (HCM) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,761,615 shares of stock. of the company stock as of 30 Sep 2025.

Institutional Holders of HUTCHMED (China) Ltd - SPONSORED ADS (HCM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,761,615 $90,656,720 -$4,321,943 $15.75 55
2025 Q2 6,069,514 $91,405,464 -$7,761,221 $15.05 61
2025 Q1 6,581,058 $99,610,173 -$4,194,044 $15.04 61
2024 Q4 6,814,654 $98,095,861 -$6,231,877 $14.41 66
2024 Q3 7,209,418 $139,718,969 -$26,521,662 $19.53 64
2024 Q2 8,722,827 $149,406,247 -$99,185,057 $17.12 64
2024 Q1 14,452,985 $242,728,014 -$19,533,352 $16.80 69
2023 Q4 15,372,070 $277,942,244 -$135,595,632 $18.11 69
2023 Q3 22,918,629 $388,740,927 -$23,192,763 $16.94 63
2023 Q2 22,038,433 $264,379,219 -$2,755,434 $12.00 64
2023 Q1 24,483,325 $318,626,357 -$34,271,355 $13.02 65
2022 Q4 27,649,301 $412,535,288 -$116,238,668 $14.78 81
2022 Q3 38,133,440 $339,493,379 -$92,590,155 $8.86 95
2022 Q2 48,442,172 $613,804,117 -$73,754,202 $12.64 98
2022 Q1 47,167,704 $896,938,367 -$70,980,227 $18.92 115
2021 Q4 50,478,195 $1,770,635,162 -$28,866,289 $35.08 134
2021 Q3 50,322,509 $1,843,716,677 +$199,066,095 $36.61 133
2021 Q2 45,726,127 $1,788,210,372 -$10,151,074 $39.27 137
2021 Q1 46,467,785 $1,311,555,368 +$5,965,685 $28.25 123
2020 Q4 45,470,486 $1,454,650,933 +$34,576,372 $32.02 117
2020 Q3 45,186,277 $1,455,133,049 +$116,984,181 $32.30 114
2020 Q2 41,982,147 $1,159,312,288 +$58,293,420 $27.58 110
2020 Q1 40,814,056 $730,879,963 +$65,623,012 $17.85 98
2019 Q4 36,778,713 $921,781,125 -$22,485,877 $25.07 103
2019 Q3 35,408,197 $632,374,823 +$27,950,407 $17.84 99
2019 Q2 34,682,105 $764,893,284 +$297,473,886 $22.00 115
2019 Q1 27,294,537 $834,492,052 +$109,972,606 $30.58 89
2018 Q4 22,018,534 $508,372,447 +$153,243,059 $23.09 72
2018 Q3 16,030,573 $515,930,578 +$15,975,583 $32.19 38
2018 Q2 15,551,933 $469,421,523 +$69,493,809 $30.14 37
2018 Q1 13,254,176 $391,795,628 +$86,078,800 $29.56 37
2017 Q4 10,221,673 $402,598,000 +$134,628,202 $39.42 37
2017 Q3 5,301,327 $144,540,000 +$10,203,159 $27.27 24
2017 Q2 4,907,304 $114,381,000 +$1,166,547 $23.31 17
2017 Q1 4,896,368 $98,277,000 -$3,203,267 $19.95 17
2016 Q4 5,116,634 $69,432,000 +$11,774,524 $13.57 13
2016 Q3 4,295,035 $51,198,000 +$9,207,700 $11.90 16
2016 Q2 185 $2,000 -$7,702,833 $10.81 1
2016 Q1 3,788,174 $50,002,000 +$49,278,076 $13.20 23